Basilea Pharmaceutica receives CHF 1.7 mn milestone payment from Asahi Kasei Pharma for strong sales of Cresemba in ...
Basilea Pharmaceutica Ltd, a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced that the sales of the antifungal Cresemba (isavuconazole) in Japan exceeded the …